These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35306936)

  • 21. Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid-sulphonamide conjugates.
    Küçükbay H; Buğday N; Küçükbay FZ; Ageli A; Bartolucci G; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):489-497. PubMed ID: 31914827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms.
    Sequeira L; Distinto S; Meleddu R; Gaspari M; Angeli A; Cottiglia F; Secci D; Onali A; Sanna E; Borges F; Uriarte E; Alcaro S; Supuran CT; Maccioni E
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270183. PubMed ID: 37870190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Handling drug-target selectivity: A study on ureido containing Carbonic Anhydrase inhibitors.
    Akgul O; Singh S; Andring JT; McKenna R; Selleri S; Carta F; Angeli A; Supuran CT
    Eur J Med Chem; 2021 Feb; 212():113035. PubMed ID: 33303238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small Molecule Alkoxy Oriented Selectiveness on Human Carbonic Anhydrase II and IX Inhibition.
    Bozdag M; Cravey L; Combs J; Kota A; McKenna R; Angeli A; Selleri S; Carta F; Supuran CT
    ChemMedChem; 2022 Jun; 17(11):e202200148. PubMed ID: 35388618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of diaryl urea molecules with and without sulfonamide group on Carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells.
    Debnath J; Keshamasetthy D; Combs J; Leon K; Vullo D; Chatterjee A; McKenna R; Supuran CT
    Bioorg Chem; 2024 Apr; 145():107192. PubMed ID: 38382393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray,
    Hefny SM; El-Moselhy TF; El-Din N; Giovannuzzi S; Bin Traiki T; Vaali-Mohammed MA; El-Dessouki AM; Yamaguchi K; Sugiura M; Shaldam MA; Supuran CT; Abdulla MH; Eldehna WM; Tawfik HO
    J Med Chem; 2024 May; 67(9):7406-7430. PubMed ID: 38642371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
    Andreucci E; Ruzzolini J; Peppicelli S; Bianchini F; Laurenzana A; Carta F; Supuran CT; Calorini L
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):117-123. PubMed ID: 30362384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses.
    Khayat MT; Ahmed HEA; Omar AM; Muhammad YA; Mohammad KA; Malebari AM; Khayyat AN; Halawa AH; Abulkhair HS; Al-Karmalawy AA; Almaghrabi M; Alharbi M; Aljahdali AS; El-Agrody AM
    J Biomol Struct Dyn; 2023; 41(24):15243-15261. PubMed ID: 36914238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy.
    Angeli A; Chelli I; Lucarini L; Sgambellone S; Marri S; Villano S; Ferraroni M; De Luca V; Capasso C; Carta F; Supuran CT
    J Med Chem; 2024 Feb; 67(4):3066-3089. PubMed ID: 38266245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of carbonic anhydrase IX-targeting molecular-targeted photodynamic therapy.
    Miura K; Nakamura H
    Bioorg Med Chem Lett; 2024 Sep; 109():129821. PubMed ID: 38810709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors.
    Pustenko A; Stepanovs D; Žalubovskis R; Vullo D; Kazaks A; Leitans J; Tars K; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):767-775. PubMed ID: 28537099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold.
    Braconi L; Riganti C; Parenti A; Cecchi M; Nocentini A; Bartolucci G; Menicatti M; Contino M; Colabufo NA; Manetti D; Romanelli MN; Supuran CT; Teodori E
    Molecules; 2024 Jul; 29(14):. PubMed ID: 39064868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting carbonic anhydrases for the management of hypoxic metastatic tumors.
    Supuran CT
    Expert Opin Ther Pat; 2023 Nov; 33(11):701-720. PubMed ID: 37545058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dehydroabietylamine-substituted trifluorobenzene sulfonamide rhodamine B hybrids as anticancer agents overcoming drug resistance.
    Heise NV; Meyer SJ; Csuk R; Mueller T
    Eur J Med Chem; 2024 Oct; 276():116667. PubMed ID: 38996651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2(
    Bilginer S; Gul HI; Erdal FS; Sakagami H; Levent S; Gulcin I; Supuran CT
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1722-1729. PubMed ID: 31576761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX.
    Žvinys G; Petrosiute A; Zakšauskas A; Zubrienė A; Ščerbavičienė A; Kalnina Z; Čapkauskaitė E; Juozapaitienė V; Mickevičiu Tė A; Shubin K; Grincevičienė Š; Raišys S; Tars K; Matulienė J; Matulis D
    Bioconjug Chem; 2024 Jun; 35(6):790-803. PubMed ID: 38750635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression Dynamics of CA IX Epitope in Cancer Cells under Intermittent Hypoxia Correlates with Extracellular pH Drop and Cell Killing by Ureido-Sulfonamide CA IX Inhibitors.
    Sufian MA; Zamanova S; Shabana AM; Kemp B; Mondal UK; Supuran CT; Ilies MA
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases.
    Fuentes-Aguilar A; González-Bakker A; Jovanović M; Stojanov SJ; Puerta A; Gargano A; Dinić J; Vega-Báez JL; Merino-Montiel P; Montiel-Smith S; Alcaro S; Nocentini A; Pešić M; Supuran CT; Padrón JM; Fernández-Bolaños JG; López Ó
    Bioorg Chem; 2024 Apr; 145():107168. PubMed ID: 38354500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.
    Cazzamalli S; Dal Corso A; Widmayer F; Neri D
    J Am Chem Soc; 2018 Feb; 140(5):1617-1621. PubMed ID: 29342352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of 3-(5-cyano-6-oxo-pyridin-2-yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity.
    Shaldam MA; Khalil AF; Almahli H; Jaballah MY; Angeli A; Khaleel EF; Badi RM; Elkaeed EB; Supuran CT; Eldehna WM; Tawfik HO
    Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300449. PubMed ID: 37828544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.